Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice

Diets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic ca...

Full description

Saved in:
Bibliographic Details
Main Authors: Jie Bai, Qiu-Yue Lin, Xiangbo An, Shuang Liu, Yao Wang, Yunpeng Xie, Jiawei Liao
Format: Article
Language:English
Published: Wiley 2022-01-01
Series:Journal of Immunology Research
Online Access:http://dx.doi.org/10.1155/2022/7909971
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832553699730259968
author Jie Bai
Qiu-Yue Lin
Xiangbo An
Shuang Liu
Yao Wang
Yunpeng Xie
Jiawei Liao
author_facet Jie Bai
Qiu-Yue Lin
Xiangbo An
Shuang Liu
Yao Wang
Yunpeng Xie
Jiawei Liao
author_sort Jie Bai
collection DOAJ
description Diets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic cardiovascular diseases is still not defined. Here, we investigated the effects of low-dose GA administration on diet-induced metabolic disorders and atherosclerosis in the atherosclerosis-prone apolipoprotein E (Apoe) knockout mice fed on a high-fat Western-type diet (WTD) for 8 weeks. Our data showed that GA administration by oral gavage at a daily dosage of 20 mg/kg body weight did not significantly ameliorate WTD-induced hyperlipidemia, hepatosteatosis, adipogenesis, or insulin resistance; furthermore, GA administration did not significantly ameliorate WTD-induced atherosclerosis. In conclusion, our data demonstrate that low-dose GA administration does not elicit significant health effect on diet-induced metabolic disorders or atherosclerosis in the Apoe knockout mice. Whether GA could be beneficial for atherosclerotic cardiovascular diseases therefore needs further exploration.
format Article
id doaj-art-9d2d9aa383644501a54d027ff1781003
institution Kabale University
issn 2314-7156
language English
publishDate 2022-01-01
publisher Wiley
record_format Article
series Journal of Immunology Research
spelling doaj-art-9d2d9aa383644501a54d027ff17810032025-02-03T05:53:27ZengWileyJournal of Immunology Research2314-71562022-01-01202210.1155/2022/7909971Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout MiceJie Bai0Qiu-Yue Lin1Xiangbo An2Shuang Liu3Yao Wang4Yunpeng Xie5Jiawei Liao6Institute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesDepartment of Interventional TherapyCollege of Basic Medical SciencesInstitute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesInstitute of Cardiovascular DiseasesDiets rich in polyphenols are known to be beneficial for cardiovascular health. Gallic acid (GA) is a plant-derived triphenolic chemical with multiple cardio-protective properties, such as antiobesity, anti-inflammation, and antioxidation. However, whether GA could protect against atherosclerotic cardiovascular diseases is still not defined. Here, we investigated the effects of low-dose GA administration on diet-induced metabolic disorders and atherosclerosis in the atherosclerosis-prone apolipoprotein E (Apoe) knockout mice fed on a high-fat Western-type diet (WTD) for 8 weeks. Our data showed that GA administration by oral gavage at a daily dosage of 20 mg/kg body weight did not significantly ameliorate WTD-induced hyperlipidemia, hepatosteatosis, adipogenesis, or insulin resistance; furthermore, GA administration did not significantly ameliorate WTD-induced atherosclerosis. In conclusion, our data demonstrate that low-dose GA administration does not elicit significant health effect on diet-induced metabolic disorders or atherosclerosis in the Apoe knockout mice. Whether GA could be beneficial for atherosclerotic cardiovascular diseases therefore needs further exploration.http://dx.doi.org/10.1155/2022/7909971
spellingShingle Jie Bai
Qiu-Yue Lin
Xiangbo An
Shuang Liu
Yao Wang
Yunpeng Xie
Jiawei Liao
Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
Journal of Immunology Research
title Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
title_full Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
title_fullStr Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
title_full_unstemmed Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
title_short Low-Dose Gallic Acid Administration Does Not Improve Diet-Induced Metabolic Disorders and Atherosclerosis in Apoe Knockout Mice
title_sort low dose gallic acid administration does not improve diet induced metabolic disorders and atherosclerosis in apoe knockout mice
url http://dx.doi.org/10.1155/2022/7909971
work_keys_str_mv AT jiebai lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT qiuyuelin lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT xiangboan lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT shuangliu lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT yaowang lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT yunpengxie lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice
AT jiaweiliao lowdosegallicacidadministrationdoesnotimprovedietinducedmetabolicdisordersandatherosclerosisinapoeknockoutmice